Search

Miltenyi Biotec explains how a platform CMC approach helps companies get their cell or gene therapy to IND submission faster.

ADC development is a complex process that can be streamlined – and optimized – by taking the right partnerships and strategies into consideration.

Tips to identify a safe, cost-efficient, and sustainable route to scalable API synthesis

Collaboration and thoughtful automation at scale will be critical for unlocking cell and gene therapies for patients

Your API is about to graduate to clinical trial manufacturing. Now what?!

Patient needs are changing, but small molecule drugs remain as important as ever. Here are some tips for development success.

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

What does sustainability look like at Cytiva?

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

It’s already used for processing powders in many industries, but here’s why pastillation should come to pharma next.